Cytodyn Inc
Change company Symbol lookup
Select an option...
CYDY Cytodyn Inc
ALMMF Aluminum Corp of China Ltd
FUN Cedar Fair LP
BAC Bank of America Corp
XLF Financial Select Sector SPDR® Fund
FRAN Francesca's Holdings Corp
ED Consolidated Edison Inc
BIIB Biogen Inc
CNF CNFinance Holdings Ltd
LVS Las Vegas Sands Corp
Go

Health Care : Biotechnology |
Company profile

CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the clinical development and commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The Company's lead product candidate, PRO 140, belongs to a class of HIV therapies known as entry inhibitors that block HIV from entering into and infecting certain cells. The Company's product pipeline also includes Cytolin and CytoFeline. Cytolin is a mouse monoclonal antibody developed to identify a specific type of immune cell called a cytotoxic T cell, or cytotoxic T lymphocyte (CTL). CytoFeline is an anti-lymphocyte function-associated antigen-1 (LFA-1) antibody for the treatment of Feline Immunodeficiency Virus (FIV) infection. PRO 140 blocks HIV from entering a cell by binding to a molecule called C-C chemokine receptor type 5 (CCR5). The Company has finished Phase II clinical trials for PRO 140 with demonstrated antiviral activity in man.

Closing Price
$6.08
Day's Change
-0.40 (-6.17%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.15
Day's Low
5.90
Volume
(Light)
Volume:
9,476,546

10-day average volume:
15,909,495
9,476,546
  • Prev Close
    6.48
  • Today's Open
    7.14
  • Day's Range
    5.90-7.15
  • Avg Vol (10-day)
    15.9M
  • Last (time)
    4:00p ET 07/02/20
  • Last (size)
    200
  • 52-Wk Range
    0.261 - 10.01
    LowHigh
  • (12/03/19 - 06/30/20)
    39.26%
  • 142.6%
  • Market Cap
    3.2B
  • Shares Outstanding
    519.7M
  • -0.21
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -0.6
  • 0.08
  • --

Latest News

July 03, 2020
6:15 pm ET
Globe Newswire
4:40 pm ET
Globe Newswire
July 02, 2020
6:00 am ET
Globe Newswire
July 01, 2020
6:00 pm ET
BusinessWire
5:37 pm ET
BusinessWire
June 30, 2020
8:45 am ET
PR Newswire
June 29, 2020
6:00 am ET
Globe Newswire
June 17, 2020
3:51 pm ET
Globe Newswire
June 11, 2020
6:59 pm ET
Globe Newswire
4:05 pm ET
Globe Newswire
June 09, 2020
6:00 am ET
Globe Newswire
June 08, 2020
6:00 am ET
Globe Newswire
June 01, 2020
6:15 am ET
Globe Newswire
6:00 am ET
Globe Newswire
May 26, 2020
9:00 am ET
PR Newswire
May 22, 2020
8:49 pm ET
Globe Newswire
May 19, 2020
6:00 am ET
Globe Newswire
May 18, 2020
6:00 am ET
Globe Newswire
May 16, 2020
12:02 pm ET
MarketWatch
May 15, 2020
6:00 am ET
Globe Newswire
May 13, 2020
6:40 am ET
Globe Newswire
May 11, 2020
6:00 am ET
Globe Newswire
May 08, 2020
7:59 pm ET
Globe Newswire
5:00 pm ET
BusinessWire
3:02 pm ET
BusinessWire
11:33 am ET
BusinessWire
7:30 am ET
BusinessWire
May 07, 2020
6:19 pm ET
Globe Newswire
May 06, 2020
1:24 am ET
Globe Newswire
May 04, 2020
12:57 pm ET
Globe Newswire
6:00 am ET
Globe Newswire
May 01, 2020
8:30 am ET
PR Newswire
April 30, 2020
6:03 am ET
Globe Newswire
April 29, 2020
2:04 pm ET
Globe Newswire
April 27, 2020
9:20 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.